Primary Health Properties PLC (PHP.L)
London, GB
Primary Health Properties (PHP) stands as the premier investor in contemporary healthcare real estate throughout the United Kingdom and Ireland. This UK-based Real Estate Investment Trust (REIT) is committed to delivering growing returns for its investors, achieved through a combination of increasing earnings and appreciating asset values. PHP accomplishes this by acquiring healthcare properties under extended lease agreements, which are underpinned by strong, government-backed financial commitments. The company manages an extensive portfolio of over 480 primary care sites, encompassing both existing facilities and planned developments. While most are general practitioner clinics, other properties are leased to various NHS entities, pharmacies, and dental practices.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.53% | -0.58% | +0.48% | -13.34% | -3.74% | -4.14% | -6.62% | -5.87% | -38.86% | -12.49% | +272.27% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth+42.5% Q4'25: +97.1% (vs Q4'23)
-
EPS growth+114.2% Q4'25: +351.6% (vs Q4'23)
-
FCF margin— Q4'25: +0.0% (vs Q4'23)
-
EBIT margin— Q4'25: +69.7% (vs Q4'23)
-
ROIC— Q4'25: +8.0% (vs Q4'23)
-
Share dilution+34.2% Q4'25: +95.0% (vs Q4'23)
-
Debt / EBITDA15.98× Q4'25: 7.01× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 8 EPS Ana. |
Dec 2027 7 Rev. Ana. 8 EPS Ana. |
Dec 2028 6 Rev. Ana. 5 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
19.69M
est: 19.21M (+2.5%)
|
21.33M
est: 22.10M (-3.5%)
|
26.92M
est: 25.48M (+5.6%)
|
30.68M
est: 29.37M (+4.5%)
|
7.16M
est: 34.27M (-79.1%)
|
28.45M
est: 41.43M (-31.3%)
|
59.99M
est: 60.70M (-1.2%)
|
63.12M
est: 62.37M (+1.2%)
|
67.40M
est: 71.29M (-5.5%)
|
72.50M
est: 71.61M (+1.2%)
|
79.60M
est: 75.70M (+5.2%)
|
121.30M
est: 114.30M (+6.1%)
|
139.00M
est: 129.12M (+7.7%)
|
145.60M
est: 137.86M (+5.6%)
|
154.10M
est: 143.80M (+7.2%)
|
169.80M
est: 177.80M (-4.5%)
|
181.70M
est: 157.02M (+15.7%)
|
259.00M
est: 210.02M (+23.3%)
|
335.43M
318.62M – 375.78M
+59.7% YoY
|
327.34M
308.50M – 365.25M
-2.4% YoY
|
329.65M
329.19M – 330.11M
+0.7% YoY
|
324.60M
307.14M – 362.93M
-1.5% YoY
|
330.15M
312.39M – 369.14M
+1.7% YoY
|
| EBITDA |
-11.67M
est: 12.30M (-194.9%)
|
7.87M
est: -69.29M (+111.4%)
|
16.98M
est: 4.61M (+268.3%)
|
25.59M
est: 18.80M (+36.1%)
|
15.59M
est: 1.68M (+827.8%)
|
36.51M
est: -26.59M (+237.3%)
|
-26.67M
est: 12.73M (-309.5%)
|
3.29M
est: -1.76M (+287.2%)
|
-222.0K
est: 21.62M (-101.0%)
|
—
est: 10.51M (-100.0%)
|
2.90M
est: 63.21M (-95.4%)
|
76.50M
est: 75.11M (+1.8%)
|
107.20M
est: -160.50M (+166.8%)
|
132.30M
est: -169.37M (+178.1%)
|
163.20M
est: -177.73M (+191.8%)
|
—
est: 114.83M (-100.0%)
|
94.70M
est: 102.17M (-7.3%)
|
207.00M
est: 135.63M (+52.6%)
|
216.63M
205.77M – 242.68M
+59.7% YoY
|
211.40M
199.23M – 235.89M
-2.4% YoY
|
212.89M
212.60M – 213.19M
+0.7% YoY
|
209.63M
198.36M – 234.39M
-1.5% YoY
|
213.22M
201.75M – 238.39M
+1.7% YoY
|
| EBIT |
5.98M
est: 12.25M (-51.2%)
|
7.87M
est: 16.88M (-53.4%)
|
22.03M
est: 20.67M (+6.6%)
|
25.53M
est: 25.21M (+1.3%)
|
14.24M
est: 29.31M (-51.4%)
|
35.94M
est: 33.41M (+7.6%)
|
25.81M
est: 50.06M (-48.4%)
|
58.75M
est: 39.76M (+47.8%)
|
59.08M
est: 45.45M (+30.0%)
|
60.00M
est: 45.65M (+31.4%)
|
69.40M
est: 48.26M (+43.8%)
|
76.50M
est: 72.87M (+5.0%)
|
107.20M
est: 8.01M (+1,238.7%)
|
132.30M
est: 8.45M (+1,465.6%)
|
163.20M
est: 8.87M (+1,740.4%)
|
-900.0K
est: 114.40M (-100.8%)
|
93.80M
est: 101.79M (-7.9%)
|
207.00M
est: 135.13M (+53.2%)
|
215.83M
205.01M – 241.79M
+59.7% YoY
|
210.62M
198.50M – 235.02M
-2.4% YoY
|
212.11M
211.81M – 212.41M
+0.7% YoY
|
208.86M
197.63M – 233.52M
-1.5% YoY
|
212.43M
201.01M – 237.52M
+1.7% YoY
|
| Net Income |
-23.90M
est: 52.43M (-145.6%)
|
10.79M
est: -26.46M (+140.8%)
|
25.68M
est: 12.37M (+107.6%)
|
12.65M
est: 29.60M (-57.3%)
|
1.13M
est: 14.76M (-92.3%)
|
20.22M
est: 1.37M (+1,379.8%)
|
36.88M
est: 29.62M (+24.5%)
|
56.03M
est: 38.50M (+45.5%)
|
43.70M
est: 62.15M (-29.7%)
|
91.90M
est: 45.16M (+103.5%)
|
74.30M
est: 98.46M (-24.5%)
|
-71.30M
est: 113.66M (-162.7%)
|
112.00M
est: -80.42M (+239.3%)
|
140.10M
est: -84.86M (+265.1%)
|
56.30M
est: -11.30M (+598.2%)
|
27.30M
est: -12.02M (+327.2%)
|
41.40M
est: 97.20M (-57.4%)
|
119.00M
est: 129.64M (-8.2%)
|
132.43M
131.18M – 133.68M
+2.2% YoY
|
136.75M
133.70M – 139.81M
+3.3% YoY
|
159.35M
113.44M – 205.26M
+16.5% YoY
|
141.11M
131.24M – 162.77M
-11.4% YoY
|
143.19M
133.18M – 165.17M
+1.5% YoY
|
| SGA |
3.52M
est: 1.43M (+145.5%)
|
3.46M
est: 4.87M (-28.9%)
|
4.65M
est: 3.97M (+17.1%)
|
5.12M
est: 5.36M (-4.4%)
|
908.0K
est: 5.97M (-84.8%)
|
3.90M
est: 1.10M (+254.0%)
|
6.78M
est: 8.91M (-23.9%)
|
6.81M
est: 7.08M (-3.9%)
|
7.30M
est: 7.55M (-3.3%)
|
8.70M
est: 7.58M (+14.8%)
|
9.90M
est: 9.32M (+6.2%)
|
12.30M
est: 15.15M (-18.8%)
|
13.20M
est: 13.87M (-4.9%)
|
10.50M
est: 14.64M (-28.3%)
|
9.60M
est: 15.36M (-37.5%)
|
12.30M
est: 9.90M (+24.2%)
|
13.00M
est: 8.81M (+47.6%)
|
—
est: 11.69M (-100.0%)
|
18.68M
17.74M – 20.92M
+59.7% YoY
|
18.23M
17.18M – 20.34M
-2.4% YoY
|
18.35M
18.33M – 18.38M
+0.7% YoY
|
18.07M
17.10M – 20.21M
-1.5% YoY
|
18.38M
17.39M – 20.55M
+1.7% YoY
|
| EPS |
-0.15
est: 0.04 (-482.4%)
|
0.07
est: 0.04 (+57.3%)
|
0.10
est: 0.04 (+132.2%)
|
0.05
est: 0.04 (+11.1%)
|
0.00
est: 0.03 (-87.4%)
|
0.06
est: 0.03 (+89.5%)
|
0.08
est: 0.04 (+112.1%)
|
0.13
est: 0.05 (+177.8%)
|
0.08
est: 0.05 (+50.2%)
|
0.15
est: 0.05 (+187.6%)
|
0.10
est: 0.05 (+88.7%)
|
-0.07
est: 0.06 (-215.1%)
|
0.09
est: 0.06 (+52.7%)
|
0.11
est: 0.06 (+78.6%)
|
0.04
est: 0.07 (-36.0%)
|
0.02
est: -0.01 (+417.1%)
|
0.03
est: 0.07 (-55.1%)
|
0.07
est: 0.07 (-8.3%)
|
0.07
0.07 – 0.07
+1.7% YoY
|
0.08
0.07 – 0.08
+3.7% YoY
|
0.08
0.06 – 0.11
+2.8% YoY
|
0.08
0.07 – 0.09
+0.2% YoY
|
0.08
0.07 – 0.09
+1.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-15 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mark Anthony Philip Davies | Chief Executive Officer & Director | 1M | male |
| Richard Howell | Chief Financial Officer & Director | 1M | male |
| Philip Higgins | Secretary | — | male |
| Sarah Taylor | Chief People Officer | — | female |
| Steven Noble | Chief Investment Officer | — | male |
| Toby Newman | Chief Legal Officer | — | male |
| David Austin | Director of Asset, Property & Facilities Management | — | male |
| Tony Coke | Director of Development | — | male |
| David Purcell | Director of Investor Relations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PHP.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
